Jiangsu Canopus Wisdom Medical Technology Co.,Ltd. (SHE:301290)
China flag China · Delayed Price · Currency is CNY
25.70
-0.47 (-1.80%)
At close: Nov 13, 2026

SHE:301290 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
426.78380.72430.47430.5440.73442.57
Other Revenue
6.776.774.993.231.373.93
433.55387.49435.46433.73442.1446.5
Revenue Growth
7.53%-11.02%0.40%-1.89%-0.98%19.25%
Cost of Revenue
214.07202.1221.08225.86210.6195.33
Gross Profit
219.48185.39214.38207.88231.5251.17
Selling, General & Admin
130.35110.17112.72106.6293.08104.58
Research & Development
24.4320.9722.4327.1124.2120.67
Other Operating Expenses
5.84.595.182.654.393.14
Operating Expenses
161.12134.99140.77135.94124.56128.17
Operating Income
58.3650.3973.671.94106.94123
Interest Expense
-0.41-1.27-0.34-0.06-0.13-0.11
Interest & Investment Income
31.0625.839.416.255.282.4
Currency Exchange Gain (Loss)
-0.51-0.51-0.14-0.020.49-0.1
Other Non Operating Income (Expenses)
-2.61-0.14-0.1-0.05-0.28-0.34
EBT Excluding Unusual Items
85.8874.26112.4288.05112.3124.85
Impairment of Goodwill
-99.72-99.72----
Gain (Loss) on Sale of Investments
2.133.01-713.690.5-
Gain (Loss) on Sale of Assets
0.02-0.04-0.09-0.59-0.43-0.25
Asset Writedown
98.08-5.63----
Other Unusual Items
-0.210.549.7315.917.445.33
Pretax Income
86.18-27.58115.06117.06119.82129.93
Income Tax Expense
13.2512.3218.1717.1816.118.86
Earnings From Continuing Operations
72.93-39.996.8999.88103.72111.07
Minority Interest in Earnings
1.541.960.53-2.66-1.21-0.82
Net Income
74.47-37.9497.4297.22102.51110.25
Net Income to Common
74.47-37.9497.4297.22102.51110.25
Net Income Growth
--0.21%-5.15%-7.03%38.33%
Shares Outstanding (Basic)
99100991007775
Shares Outstanding (Diluted)
99100991007775
Shares Change
-1.60%0.43%-0.81%30.05%2.76%10.45%
EPS (Basic)
0.76-0.380.980.971.331.47
EPS (Diluted)
0.76-0.380.980.971.331.47
EPS Growth
--1.03%-27.07%-9.52%25.64%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
36.3938.0310.5451.6820.2867.78
Free Cash Flow Per Share
0.370.380.110.520.260.90
Dividend Per Share
0.3000.3000.6000.6000.500-
Dividend Growth
-50.00%-50.00%0%20.00%--
Gross Margin
50.62%47.84%49.23%47.93%52.36%56.25%
Operating Margin
13.46%13.00%16.90%16.59%24.19%27.55%
Profit Margin
17.18%-9.79%22.37%22.41%23.19%24.69%
Free Cash Flow Margin
8.39%9.81%2.42%11.91%4.59%15.18%
EBITDA
98.7191.52115.76109.58141.18150.64
EBITDA Margin
22.77%23.62%26.58%25.26%31.93%33.74%
D&A For EBITDA
40.3541.1242.1537.6434.2427.64
EBIT
58.3650.3973.671.94106.94123
EBIT Margin
13.46%13.00%16.90%16.59%24.19%27.55%
Effective Tax Rate
15.38%-15.79%14.68%13.44%14.52%
Revenue as Reported
103.75387.49435.46433.73442.1446.5
Advertising Expenses
-1.642.071.871.342.48